Tag

• UGI USER
• CDSCO fatty liver disease India health news liver disease treatment MASH medical approval India NASH Semaglutide UPSC Current Affairs Wegovy
• 5
• 0

CDSCO Approves Wegovy for MASH Fatty Liver Disease

CDSCO APPROVES WEGOVY FOR TREATMENT OF MASH (FATTY LIVER DISEASE) Why in the News? Regulatory Approval: The Central Drugs Standard Control Organisation (CDSCO) has approved Wegovy (Semaglutide 2.4 mg) for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in adults, reflecting India’s participation in global pharmaceutical strategic competition. First-of-Its-Kind Therapy: It is the first injectable GLP-1 …

Read More